Redefining MDR-TB transmission 'hot spots'. Mercedes Becerra Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY. Mon, 05/01/2000 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/10815730
Community-based approaches to HIV treatment in resource-poor settings. Mercedes Becerra Farmer P, Léandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY. Sat, 08/04/2001 - 12:00 Lancet http://www.ncbi.nlm.nih.gov/pubmed/11502340
Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Mercedes Becerra Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Tue, 02/01/2000 - 12:00 Eur J Clin Microbiol Infect Dis http://www.ncbi.nlm.nih.gov/pubmed/10746502
The dilemma of MDR-TB in the global era. Mercedes Becerra Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Sun, 11/01/1998 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/9848606
Management of MDR-TB in resource-poor countries. Mercedes Becerra Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Sun, 08/01/1999 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/10460095
Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Mercedes Becerra Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Tue, 02/01/2000 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/10694087
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Mercedes Becerra Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Sun, 07/01/2001 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/11467371
Isoniazid resistance and the future of drug-resistant tuberculosis. Mercedes Becerra Cohen T, Becerra MC, Murray MB. Thu, 01/01/2004 - 12:00 Microb Drug Resist http://www.ncbi.nlm.nih.gov/pubmed/15650371
Programmes and principles in treatment of multidrug-resistant tuberculosis. Mercedes Becerra Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Sat, 02/07/2004 - 12:00 Lancet http://www.ncbi.nlm.nih.gov/pubmed/14962530
Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. Mercedes Becerra Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Mon, 12/01/2003 - 12:00 Int J Tuberc Lung Dis http://www.ncbi.nlm.nih.gov/pubmed/14677844
